Drug Markets/Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine and Tenofovir Disoproxil Fumarate

21 NDCs across 16 manufacturers|20 Generic,1 Brand

▸ More about this market

Emtricitabine and Tenofovir Disoproxil Fumarate is available as 21 NDCs from 16 manufacturers (20 generic, 1 brand), with NADAC prices from $0.45 to $59.62 per EA — the most expensive product costs about 132× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

20G / 1B

Manufacturers

competing in market

Price Spread

$0.45 – $59.62

per EA

7d Activity

30↑3↓-12 flat

avg +5.5% WoW · of 21 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

16 manufacturers producing EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE(1 pricing outlier)

Zydus Pharmaceuticals (USA) Inc.

2 NDCs

$5.3498

avg/unit

Aurobindo Pharma Limited

2 NDCs

$5.3498

avg/unit

Amneal Pharmaceuticals NY LLC

Gilead Sciences, Inc.

Exelan Pharmaceuticals Inc.

1 NDC

$0.5694

avg/unit

Teva Pharmaceuticals USA Inc.

1 NDC

$0.5051

avg/unit

Quallent Pharmaceuticals Health LLC

1 NDC

$0.5051

avg/unit

Major Pharmaceuticals

Camber Pharmaceuticals Inc.

1 NDC

$0.5051

avg/unit

Macleods Pharmaceuticals Limited

American Health Packaging

1 NDC

$0.4572

avg/unit

Mylan Pharmaceuticals Inc.

1 NDC

$0.4508

avg/unit

Drug Portfolio

21 NDCs total, 21 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
TRUVADA 200 MG-300 MG TABLET	61958070101	Gilead Sciences, Inc.	$59.6236 per EA	High Outlier	Brand	-0.13%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB	70710136403	Zydus Pharmaceuticals (USA) Inc.	$10.1945 per EA	High Outlier	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB	59651016530	Aurobindo Pharma Limited	$10.1945 per EA	High Outlier	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB	69238209203	Amneal Pharmaceuticals NY LLC	$10.1945 per EA	High Outlier	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	69097074102	Cipla USA Inc.	$0.6002 per EA	—	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	69097020902	Cipla USA Inc.	$0.6002 per EA	—	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	76282067730	Exelan Pharmaceuticals Inc.	$0.5694 per EA	—	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	69238209503	Amneal Pharmaceuticals NY LLC	$0.5051 per EA	High Outlier	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	70710136703	Zydus Pharmaceuticals (USA) Inc.	$0.5051 per EA	High Outlier	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	00093770456	Teva Pharmaceuticals USA Inc.	$0.5051 per EA	—	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	82009010930	Quallent Pharmaceuticals Health LLC	$0.5051 per EA	—	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	00904717207	Major Pharmaceuticals	$0.5051 per EA	—	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	16714053401	NorthStar Rx LLC	$0.5051 per EA	—	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	31722056030	Camber Pharmaceuticals Inc.	$0.5051 per EA	—	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	33342010607	Macleods Pharmaceuticals Limited	$0.5051 per EA	—	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	42385095330	Laurus Labs Limited	$0.5051 per EA	—	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	65862035430	Aurobindo Pharma Limited	$0.5051 per EA	High Outlier	Generic	+6.01%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	60687071925	American Health Packaging	$0.4572 per EA	—	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	64380071904	Strides Pharma Inc.	$0.4508 per EA	—	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	42543071904	Strides Pharma Inc.	$0.4508 per EA	—	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB	00378193093	Mylan Pharmaceuticals Inc.	$0.4508 per EA	—	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Frequently Asked Questions

How many Emtricitabine and Tenofovir Disoproxil Fumarate products are on the market?

The Emtricitabine and Tenofovir Disoproxil Fumarate drug market contains 21 NDCs from 16 manufacturers — 20 generic and 1 brand product.

What is the price range for Emtricitabine and Tenofovir Disoproxil Fumarate?

NADAC reference prices for Emtricitabine and Tenofovir Disoproxil Fumarate range from $0.4508 to $59.6236 per EA — the most expensive product costs about 132× the cheapest.

Is generic Emtricitabine and Tenofovir Disoproxil Fumarate cheaper than brand?

The average generic NADAC for Emtricitabine and Tenofovir Disoproxil Fumarate is $1.9607 per EA, versus $59.6236 for brand-labeled products — brand versions average about 30× the generic price.

Which manufacturers make Emtricitabine and Tenofovir Disoproxil Fumarate?

16 manufacturers list Emtricitabine and Tenofovir Disoproxil Fumarate in NADAC. Ranked by number of NDCs, the largest are Zydus Pharmaceuticals (USA) Inc. (2), Aurobindo Pharma Limited (2), Amneal Pharmaceuticals NY LLC (2), Cipla USA Inc. (2), Strides Pharma Inc. (2).

How has the price of Emtricitabine and Tenofovir Disoproxil Fumarate changed recently?

Over the past 7 days, 30 Emtricitabine and Tenofovir Disoproxil Fumarate NDCs rose and 3 fell, with a market-wide average change of +5.5%.